To provide an information resource for UK anaplastic lymphoma kinase (ALK) positive lung cancer patients, in particular access to information about latest developments and clinical trials.
To liaise with and influence decision makers, eg NICE, NHS, DVLA.
To liaise with relevant organisations, in particular Roy Castle Lung Cancer Foundation and the pharmaceutical industry.
To identify and locate UK ALK patients and to offer support and guidance on the location of UK ALK specialist and services.
To raise awareness of ALK lung cancer, particularly among the medical profession, so as to promote the best treatment for patients.
To raise funds to advance these aims.